Thomas J. van Haarlem
Nessuna posizione attualmente
Profilo
Thomas J.
van Haarlem was the founder who founded Aerie Pharmaceuticals, Inc. in 2005, where he held the titles of President, Chief Executive Officer & Director until 2013.
He also worked as a Principal at Merck & Co., Inc., Vice President-Surgical Ophthalmology at Pfizer Inc., and Vice President-Commercial Development at Pharmacia Corp.
Dr. van Haarlem holds a doctorate degree from the University of Amsterdam.
Precedenti posizioni note di Thomas J. van Haarlem
Società | Posizione | Fine |
---|---|---|
AERIE PHARMACEUTICALS, INC. | Fondatore | 25/07/2013 |
MERCK & CO., INC. | Corporate Officer/Principal | - |
PFIZER, INC. | Corporate Officer/Principal | - |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | - |
Formazione di Thomas J. van Haarlem
University of Amsterdam | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
PFIZER, INC. | Health Technology |
Aziende private | 2 |
---|---|
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Borsa valori
- Insiders
- Thomas J. van Haarlem